Qube Research & Technologies (QRT)
PRVA icon

Qube Research & Technologies (QRT)’s Privia Health PRVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8M Buy
848,154
+281,359
+50% +$6.52M 0.02% 868
2026
Q1 		$11.7M Buy
566,795
+290,962
+105% +$6.56M 0.01% 1184
2025
Q4 		$6.54M Buy
275,833
+213,205
+340% +$5.19M 0.01% 1609
2025
Q3 		$1.56M Sell
62,628
-546,650
-90% -$11.8M ﹤0.01% 2342
2025
Q2 		$14M Buy
609,278
+294,101
+93% +$6.81M 0.01% 1094
2025
Q1 		$7.08M Sell
315,177
-13,613
-4% -$316K 0.01% 1345
2024
Q4 		$6.43M Buy
328,790
+38,572
+13% +$764K 0.01% 1350
2024
Q3 		$5.28M Buy
290,218
+253,998
+701% +$4.85M 0.01% 1365
2024
Q2 		$630K Buy
36,220
+27,366
+309% +$485K ﹤0.01% 2070
2024
Q1 		$173K Buy
+8,854
New +$187K ﹤0.01% 3088
2023
Q1 		– Sell
-75,763
Closed -$1.72M – 2925
2022
Q4 		$1.72M Buy
75,763
+31,209
+70% +$869K 0.01% 1002
2022
Q3 		$1.52M Buy
+44,554
New +$1.65M 0.01% 1041
2022
Q1 		– Sell
-22,648
Closed -$586K – 2877
2021
Q4 		$586K Buy
22,648
+12,361
+120% +$308K ﹤0.01% 1491
2021
Q3 		$242K Buy
+10,287
New +$359K ﹤0.01% 1574

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRVA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Privia Health (PRVA) stake by 50% in Q2 2026, buying an estimated $6.52M and bringing the position to 848,154 shares worth $21.8M. The position accounts for 0.02% of the portfolio, ranked #868.

Qube Research & Technologies (QRT) first reported a position in PRVA in Q3 2021 and has held it in 14 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 848,154 shares of Privia Health worth $21.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 281,359 Privia Health shares in Q2 2026, an estimated $6.52M.
  • Privia Health made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #868 holding.
  • Qube Research & Technologies (QRT) first reported a position in Privia Health in Q3 2021 and has held it in 14 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.